![]()
|
|
||||||||
J. Biol. Chem., Vol. 269, Issue 31, 19848-19858, 08, 1994
GK Scott, JC Daniel, X Xiong, RA Maki, D Kabat and CC Benz
Promoter elements accounting for HER2 (c-erbB-2/neu) overexpression were
searched for in several human breast cancer cell lines (MDA-453, BT-474,
ZR-75-1, MCF-7) known to express constitutively a 30-fold range in HER2
transcripts per gene copy. HER2 overexpressing cells showed a single
prominent DNase I hypersensitive site near a conserved and hitherto
unrecognized ets response element (GAGGAA), located 38 bases down-stream
from the CAAT box and directly 5' of the TATA box in the human HER2
promoter. Transient transfection of HER2 promoter constructs (0.125, 0.5,
and 2.0 kilobase pairs (kb)) demonstrated that the most proximal promoter
region (0.125 kb) was capable of conferring up to 30- fold enhanced
activity in HER2-overexpressing cell lines relative to low HER2-expressing
control lines. Site-directed mutagenesis of the ets response element
(GAGGAA-->GAGAGA) caused a > or = 60% reduction in promoter activity
affecting at least 0.5 kb of upstream HER2 regulatory sequence. Gel-shift
assays with nuclear extracts and oligonucleotide sequences spanning the
0.125-kb promoter region detected an ETS- immunoreactive complex, present
most abundantly in cells overexpressing HER2, whose high-affinity binding
depended on the GAGGAA response element. Methylation interference confirmed
the ETS-specific pattern of protein binding by this complex to guanine
bases in the ets response element. UV cross-linking and immunoprecipitation
implicate a approximately 60-kDa ETS protein, and candidate ETS genes
expressed in these breast cancer cells include GABP alpha, elk-1, elf-1,
and PEA3.
Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells
Cancer Research Institute, University of California, San Francisco 94143-0128.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Hu, M. Chouinard, A. L. Cox, P. Sipes, M. Marcelo, J. Ficorilli, S. Li, H. Gao, T. P. Ryan, M. D. Michael, et al. Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation J. Biol. Chem., December 29, 2006; 281(52): 39831 - 39838. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Evert, J. Araujo, A. M. Vieira-Saecker, R. A. I. de Vos, S. Harendza, T. Klockgether, and U. Wullner Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation. J. Neurosci., November 1, 2006; 26(44): 11474 - 11486. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Pawlitzky, C. V. Angeles, A. M. Siegel, M. L. Stanton, R. Riblet, and P. H. Brodeur Identification of a Candidate Regulatory Element within the 5' Flanking Region of the Mouse Igh Locus Defined by Pro-B Cell-Specific Hypersensitivity Associated with Binding of PU.1, Pax5, and E2A. J. Immunol., June 1, 2006; 176(11): 6839 - 6851. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Zhong, J. S. Maltzman, E. A. Hainey, and G. A. Koretzky Transcriptional Regulation of Src Homology 2 Domain-Containing Leukocyte Phosphoprotein of 76 kDa: Dissection of Key Promoter Elements J. Immunol., December 15, 2003; 171(12): 6621 - 6629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Asada, Y. Choi, M. Yamada, S.-C. Wang, M.-C. Hung, J. Qin, and M. Uesugi External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator PNAS, October 1, 2002; 99(20): 12747 - 12752. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Scott, C. Marden, F. Xu, L. Kirk, and C. C. Benz Transcriptional Repression of ErbB2 by Histone Deacetylase Inhibitors Detected by a Genomically Integrated ErbB2 Promoter-reporting Cell Screen Mol. Cancer Ther., April 1, 2002; 1(6): 385 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Margana, K. Berhane, M. N. Alam, and V. Boggaram Identification of functional TTF-1 and Sp1/Sp3 sites in the upstream promoter region of rabbit SP-B gene Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L477 - L484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Suen and P. E. Goss Characterization of a Repressor Element and a Juxtaposed Tissue-restricted Activator Element Located on the Distal neu Gene Promoter J. Biol. Chem., February 25, 2000; 275(9): 6600 - 6607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grooteclaes, D. Vernimmen, S. Plaza, F. Pasleau, D. Hodzic, and R. Winkler-Gol A New cis Element Is Involved in the HER2 Gene Overexpression in Human Breast Cancer Cells Cancer Res., June 1, 1999; 59(11): 2527 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hoare, J. A. Copland, T. G. Wood, Y.-J. Jeng, M. G. Izban, and M. S. Soloff Identification of a GABP{alpha}/{beta} Binding Site Involved in the Induction of Oxytocin Receptor Gene Expression in Human Breast Cells. Potentiation by c-Fos/c-Jun Endocrinology, May 1, 1999; 140(5): 2268 - 2279. [Abstract] [Full Text] |
||||
![]() |
A. S. Takaoka, T. Yamada, M. Gotoh, Y. Kanai, K. Imai, and S. Hirohashi Cloning and Characterization of the Human beta 4-Integrin Gene Promoter and Enhancers J. Biol. Chem., December 11, 1998; 273(50): 33848 - 33855. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Neve, C. Chang, G. K. Scott, A. Wong, R. R. Friis, N. E. Hynes, and C. C. Benz The epithelium-specific Ets transcription factor ESX is associated with mammary gland development and involution FASEB J, November 1, 1998; 12(14): 1541 - 1550. [Abstract] [Full Text] |
||||
![]() |
M. Ohmori, T. Endo, N. Harii, and T. Onaya A Novel Thyroid Transcription Factor Is Essential for Thyrotropin-Induced Up-Regulation of Na+/I- Symporter Gene Expression Mol. Endocrinol., May 1, 1998; 12(5): 727 - 736. [Abstract] [Full Text] |
||||
![]() |
C. K. Galang, J. J. García-Ramírez, P. A. Solski, J. K. Westwick, C. J. Der, N. N. Neznanov, R. G. Oshima, and C. A. Hauser Oncogenic Neu/ErbB-2 Increases Ets, AP-1, and NF-kappaB-dependent Gene Expression, and Inhibiting Ets Activation Blocks Neu-mediated Cellular Transformation J. Biol. Chem., April 5, 1996; 271(14): 7992 - 7998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Chiang, R. W. Burli, C. C. Benz, L. Gawron, G. K. Scott, P. B. Dervan, and T. A. Beerman Targeting the Ets Binding Site of the HER2/neu Promoter with Pyrrole-Imidazole Polyamides J. Biol. Chem., August 4, 2000; 275(32): 24246 - 24254. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |